JAK2 and ovarian carcinoma: CHAF1A promotes the proliferation and growth of epithelial ovarian cancer cells and inhibits the apoptosis of cancer cells by activating JAK2/STAT3 signaling pathway, which is expected to be a new target for the treatment of epithelial ovarian cancer.